Side effects of therapy for chronic hepatitis C

被引：212

作者：

Russo, MW ^{[1
]}

Fried, MW ^{[1
]}

机构：

[1] Univ N Carolina, Div Digest Dis, Chapel Hill, NC 27599 USA

来源：

GASTROENTEROLOGY | 2003年 / 124卷 / 06期

关键词：

D O I：

10.1016/S0016-5085(03)00394-9

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

收藏

页码：1711 / 1719

页数：9

相关论文

共 63 条

[1]

[Anonymous], 2002, Gastroenterology, V123, P2082, DOI 10.1053/gast.2002.1232082

[2] Autoimmunity against pancreatic islets and other tissues before and after interferon-α therapy in patients with hepatitis C virus chronic infection [J].

Betterle, C ;

Fabris, P ;

Zanchetta, R ;

Pedini, B ;

Tositti, G ;

Bosi, E ;

de Lalla, F .

DIABETES CARE, 2000, 23 (08) :1177-1181

[3] Increased depressive ratings in patients with hepatitis C receiving interferon-α-based immunotherapy are related to interferon-α-induced changes in the serotonergic system [J].

Bonaccorso, S ;

Marino, V ;

Puzella, A ;

Pasquini, M ;

Biondi, M ;

Artini, M ;

Almerighi, C ;

Verkerk, R ;

Meltzer, H ;

Maes, M .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (01) :86-90

[4] Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms [J].

Bonaccorso, S ;

Puzella, A ;

Marino, V ;

Pasquini, M ;

Biondi, M ;

Artini, M ;

Almerighi, C ;

Levrero, M ;

Egyed, B ;

Bosmans, E ;

Meltzer, HY ;

Maes, M .

PSYCHIATRY RESEARCH, 2001, 105 (1-2) :45-55

[5] Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: A case report and literature review [J].

Boonyapisit, K ;

Katirji, B .

MUSCLE & NERVE, 2002, 25 (06) :909-913

[6] Cryoglobulinemia vasculitis [J].

Cacoub, P ;

Costedoat-Chalumeau, N ;

Lidove, O ;

Alric, L .

CURRENT OPINION IN RHEUMATOLOGY, 2002, 14 (01) :29-35

[7] Long-term outcome of interferon-α-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment [J].

Carella, C ;

Mazziotti, G ;

Morisco, F ;

Manganella, G ;

Rotondi, M ;

Tuccillo, C ;

Sorvillo, F ;

Caporaso, N ;

Amato, G .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (05) :1925-1929

[8] Randomized controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor for the treatment of chronic hepatitis C [J].

Carreño, V ;

Martín, J ;

Pardo, M ;

Brotons, A ;

Anchía, P ;

Navas, S ;

Fernández, M ;

Arocena, C ;

Quiroga, JA .

CYTOKINE, 2000, 12 (02) :165-170

[9] Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: Role of membrane oxidative damage [J].

De Franceschi, L ;

Fattovich, G ;

Turrini, F ;

Ayi, K ;

Brugnara, C ;

Manzato, F ;

Noventa, F ;

Stanzial, AM ;

Solero, P ;

Corrocher, R .

HEPATOLOGY, 2000, 31 (04) :997-1004

[10] Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy [J].

Deutsch, M ;

Dourakis, S ;

Manesis, EK ;

Gioustozi, A ;

Hess, G ;

Horsch, A ;

Hadziyannis, S .

HEPATOLOGY, 1997, 26 (01) :206-210

← 1 2 3 4 5 6 7 →